Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001493152-26-045809

10% owner bought 60,490 shares at an average $2.05 ($123,819)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Opaleye Management Inc. 10% owner 2026-10-01 Purchase +38,796 $2.04 $78,961 2,836,963 I
Opaleye Management Inc. 10% owner 2026-10-02 Purchase +20,000 $2.07 $41,368 2,856,963 I
Opaleye Management Inc. 10% owner 2026-10-05 Purchase +1,694 $2.06 $3,490 2,858,657 I
Open-market purchases · 60,490 sh · avg $2.05 · $123,819
Loading xslF345X06/ownership.xml…